CoChat

A B56γ mutation in lung cancer disrupts the p53-dependent tumor-suppressor function of protein phosphatase 2A

Open access
Shouse, G P, Nobumori, Y, Liu, X · 2010 · Oncogene
Cited by 49

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Abstract

Earlier studies have shown both p53-dependent and -independent tumor-suppressive functions of B56γ-specific protein phosphatase 2A (B56γ–PP2A). In the absence of p53, B56γ–PP2A can inhibit cell proliferation and cell transformation by an unknown mechanism. In the presence of p53, on DNA damage, a complex including B56γ–PP2A and p53 is formed, which leads to Thr55 dephosphorylation of p53, induction of the p53 transcriptional target p21 and inhibition of cell proliferation. In spite of its significance in inhibition of cell proliferation, no B56γ mutations have been linked to human cancer to date. In this study, we first differentiate between the p53-dependent and -independent functions of B56γ–PP2A by identifying a domain of the B56γ protein required for interaction with p53. Within this region, we identify a B56γ mutation, F395C, in lung cancer that disrupts the B56γ–p53 interaction. More importantly, we show that F395C is unable to promote p53 Thr55 dephosphorylation, transcriptional activation of p21 and the p53-dependent tumor-suppressive function of PP2A. This finding provides a mechanistic basis for the p53-dependent and -independent functions of B56γ–PP2A and establishes a critical link between B56γ–PP2A p53-dependent tumor-suppressive function and tumorigenesis.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/onc.2010.161

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Cited by

See all 49

Metadata

Authors
Shouse, G. P., Nobumori, Y., & Liu, X.
Venue
Oncogene
Published
2010-05-17
Volume
29
Issue
27
Pages
3933-3941
ISSN
  • 0950-9232 (ISSN-L)
  • 1476-5594
OpenAlex
W2011782300
Cited by
49
References
9
FWCI
2.99
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.